|
Prostatitis
|
D011472 |
[Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
] |
|
6-deoxy-(pyrene-1-carboxamido)-beta-cyclodextrin
|
C481927 |
|
|
(2S,3S)-1-amino-2,3-diphenylcyclopropanecarboxylic acid
|
C481928 |
|
|
Prosthesis Design
|
D011474 |
[The plan and delineation of prostheses in general or a specific prosthesis.
] |
|
Tu 2208
|
C481929 |
|
|
Prosthesis Failure
|
D011475 |
[Malfunction of implantation shunts, valves, etc., and prosthesis loosening, migration, and breaking.
] |
|
Prosthodontics
|
D011476 |
[A dental specialty concerned with the restoration and maintenance of oral function by the replacement of missing TEETH and related structures by artificial devices or DENTAL PROSTHESES.
] |
|
octyldodecyl stearoyl stearate
|
C456970 |
|
|
2-ethylhexyl stearate
|
C456971 |
|
|
octyl dodecanol
|
C456972 |
|
|
stearamide dihydroxyisobutylamine-stearate
|
C456973 |
|
|
cetethyl morpholinium
|
C456974 |
|
|
ATOH7 protein, human
|
C456975 |
|
|
ELP4 protein, human
|
C456976 |
|
|
5-O-caffeoyl quinic acid butyl ester
|
C481910 |
|
|
cycloclausenamide
|
C481911 |
|
|
Protein Disulfide Reductase (Glutathione)
|
D011490 |
[An enzyme that catalyzes the reduction of a protein-disulfide in the presence of glutathione, forming a protein-dithiol. Insulin is one of its substrates. EC 1.8.4.2.
] |
|
integramide A
|
C456979 |
|
|
2-(morpholinomethyl)pyrrolidine
|
C442340 |
|
|
Protein Deficiency
|
D011488 |
[A nutritional condition produced by a deficiency of proteins in the diet, characterized by adaptive enzyme changes in the liver, increase in amino acid synthetases, and diminution of urea formation, thus conserving nitrogen and reducing its loss in the urine. Growth, immune response, repair, and production of enzymes and hormones are all impaired in severe protein deficiency. Protein deficiency may also arise in the face of adequate protein intake if the protein is of poor quality (i.e., the content of one or more amino acids is inadequate and thus becomes the limiting factor in protein utilization). (From Merck Manual, 16th ed; Harrison's Principles of Internal Medicine, 12th ed, p406)
] |
